Displaying items by tag: division of infectious diseases

Vaccines are scientifically proven to save lives and prevent major outbreaks of highly infectious diseases among large populations in a safe and effective way.

A groundbreaking clinical research trial at UAB’s Alabama Vaccine Research Clinic to compare injectable PrEP versus a daily oral regimen for HIV prevention is now recruiting participants. 

Scientists from around the world will gather at UAB in December to focus on HIV research and women, particularly collaborative research on women living with HIV and those at risk.
Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.

A UAB expert recommends international travelers consult with a physician four to six weeks prior to travel and learn medical risks and how to prevent illness while abroad. 

High mosquito and human population densities, combined with mosquito breeding conditions, are the central cause for Zika virus.
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
Page 9 of 11